According to the Legislative Budget Board (LBB), HB 721 is not expected to result in any significant fiscal implications to the State of Texas. The analysis assumes that any administrative costs associated with implementing the bill could be managed within existing agency resources and budgets. Therefore, no additional appropriations or staffing increases would be necessary to support the bill's changes.

At the local level, the bill is also projected to have no significant fiscal impact on city, county, or other regional governmental units. This finding aligns with the bill’s narrow focus—modifying disclosure requirements under the Insurance Code, rather than imposing new mandates or cost burdens on local health program administrators.

Relevant state agencies, including the Employees Retirement System, the Health and Human Services Commission, and administrative offices from both the Texas A&M University System and the University of Texas System, reviewed the bill and did not identify cost concerns. This fiscal neutrality is largely due to the nature of the bill, which exempts certain local health care programs from compliance with existing health care cost disclosure statutes rather than adding new regulatory obligations.

HB 721 seeks to exempt certain regional or local health care programs, such as the UTMB Health Multi-Share Plan, from existing state laws requiring health benefit plans to disclose the cost of care. The bill's intent is to preserve the viability of small-scale, nonprofit-style health coverage programs that operate with capped enrollment and modest budgets. The bill author argues that the administrative burden of complying with full transparency regulations would threaten the continued operation of these programs, which provide a basic level of coverage to workers who might otherwise be uninsured.

However, while the intent is understandable, the approach taken in HB 721 substantially violates several core liberty principles—specifically, Individual Liberty, Personal Responsibility, and Free Enterprise. Transparency in pricing is fundamental to empowering consumers to make informed decisions about their health care. Exempting certain plans from these requirements undermines the uniformity and integrity of consumer protection laws. It also reduces market accountability and could create competitive imbalances where some health plans are held to higher standards than others, despite serving similar populations.

Furthermore, the bill could set a problematic precedent by allowing economic or administrative hardship to justify broad exemptions from transparency standards, rather than encouraging regulatory adaptation. Rather than exempting these programs entirely, the Legislature should explore amending the bill to implement proportional, simplified reporting requirements. This would allow localized programs to remain viable while still ensuring their enrollees receive basic information about health care pricing and coverage. Another constructive amendment would be to sunset the exemption after a trial period, subject to review and reauthorization based on performance and transparency outcomes.

Until those kinds of amendments are adopted, this legislation weakens key protections for health care consumers and risks opening the door to further carve-outs that dilute market transparency. Therefore, Texas Policy Research recommends that lawmakers vote NO on HB 721 unless amended as described above.

• Individual Liberty: Individual liberty is grounded in a person's ability to make informed, autonomous decisions. Cost transparency laws are designed to ensure that consumers have access to clear information about the price of health care services before receiving them. By exempting certain local and regional health plans from these requirements, the bill denies enrollees the same visibility into costs that is required from other plans. This reduces the ability of individuals to freely choose based on price and value, and undermines their control over health-related financial decisions.
• Personal Responsibility: A free society expects individuals to take personal responsibility for managing their health care choices. But this responsibility is only meaningful if individuals are equipped with the necessary tools, chief among them, transparent cost data. The bill removes that tool for consumers in affected plans, thereby weakening their capacity to act responsibly in the marketplace. When cost information is obscured, patients are less able to budget, compare, or question charges, all of which are behaviors tied directly to responsible decision-making.
• Free Enterprise: Transparency enhances competition. When all plans play by the same rules, the market can reward efficiency and affordability. The bill disrupts this by giving specific local programs a regulatory exemption not afforded to their competitors. This creates an uneven playing field, distorting market dynamics and insulating certain plans from competitive pressure. Over time, this may reduce incentives for cost control and innovation, harming the very consumers the plans are designed to help.
• Private Property Rights: This bill does not directly infringe on property rights, such as the right to own, use, or dispose of personal or business property. However, from a broader economic liberty perspective, restricting access to market information can lead individuals to make less-informed decisions about how to use their financial resources—an indirect erosion of the principle that people should be able to control their assets freely and knowledgeably.
• Limited Government: The bill is framed as a deregulation measure, which could be viewed as consistent with the principle of limited government. It seeks to reduce regulatory burdens on small, localized programs that may be disproportionately affected by cost-reporting mandates designed for larger insurers. However, limited government does not mean selective enforcement or special treatment. True limited government also requires consistent, fair application of the law. Granting exemptions to a narrow category of entities introduces new complexity and could necessitate further oversight or litigation to determine eligibility and compliance, paradoxically expanding government involvement in the long run.